SB 627 | Author: | Zaffirini |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to the licensing and regulation of dietitians. |
SB 918 | Author: | Zaffirini |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to the licensing and regulation of orthotists and prosthetists. |
SB 1113 | Author: | Hughes |
Sponsor: | VanDeaver | |
Last Action: | 05/24/2025 H Committee report sent to Calendars | |
Caption: | Relating to certain retail sales of motor vehicles, trailers, and semitrailers by a holder of a converter's license. |
SB 1369 | Author: | Hughes |
Sponsor: | VanDeaver | |
Last Action: | 05/19/2025 E Effective on 9/1/25 | |
Caption: | Relating to the designation of a portion of State Highway 11 in Morris County as the Army Staff Sergeant Samuel T. Castle Memorial Highway. |
SB 1376 | Author: | Hughes |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective immediately | |
Caption: | Relating to the supervision requirements of a code enforcement officer in training. |
SB 1580 | Author: | Blanco |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to the composition of the governing body of a local mental health authority. |
SB 1677 | Author: | Menéndez |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to a study on prevention and reduction of diabetes-related amputation. |
SB 1697 | Author: | Zaffirini |
Sponsor: | VanDeaver | |
Last Action: | 05/13/2025 E Effective on 9/1/25 | |
Caption: | Relating to a customer guide to home solar energy devices. |
SB 1786 | Author: | Creighton |
Sponsor: | VanDeaver | King | Ward Johnson | Kitzman | |
Last Action: | 05/27/2025 E See remarks for effective date | |
Caption: | Relating to public higher education. |
SB 1940 | Author: | Hughes |
Sponsor: | VanDeaver | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to authorizing a beneficiary designation that transfers a manufactured home classified as personal property at the owner's death. |
SB 1986 | Author: | Hall |
Sponsor: | VanDeaver | |
Last Action: | 05/26/2025 H Placed on General State Calendar | |
Caption: | Relating to warning labels for opioid prescription drugs. |
SB 2785 | Author: | Birdwell |
Sponsor: | VanDeaver | |
Last Action: | 05/26/2025 H Placed on General State Calendar | |
Caption: | Relating to notification and disclosure of records and information concerning an investigation of a report of child abuse or neglect to county or district attorneys. |
SB 25 | Author: | Kolkhorst |
Sponsor: | Hull | Frank | VanDeaver | Bucy | Pierson | |
Last Action: | 06/22/2025 E Effective on 9/1/25 | |
Caption: | Relating to health and nutrition standards to promote healthy living, including requirements for food labeling, primary and secondary education, higher education, and continuing education for certain health care professionals; authorizing a civil penalty. |
SB 261 | Author: | Perry |
Sponsor: | Gerdes | Kitzman | VanDeaver | Bell, Keith | Dean | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to a prohibition on the offering for sale and the sale of cell-cultured protein for human consumption; providing civil and criminal penalties. |
SB 991 | Author: | Bettencourt |
Sponsor: | González, Mary | Moody | VanDeaver | Garcia, Linda | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to the inclusion of chronically absent and truant students as students at risk of dropping out of school and the collection and reporting of data regarding those students. |
SB 1233 | Author: | Hancock |
Sponsor: | Swanson | Oliverson | VanDeaver | Bonnen | Leach | |
Last Action: | 06/20/2025 E Effective on 9/1/25 | |
Caption: | Relating to information regarding perinatal palliative care; creating an administrative penalty. |
SB 2308 | Author: | Parker |
Sponsor: | Harris | Leach | Phelan | Orr | VanDeaver | |
Last Action: | 06/11/2025 E Effective immediately | |
Caption: | Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment. |